Mary E Abood

发表

[Table, Primary Screen Protocol].

Susanne Heynen-Genel, Michelle Sauer, Shenghua Shi, 2010 .

Table 5A, Submission information on Probe 1: CID2286812 and analogs

Susanne Heynen-Genel, Michelle Sauer, Shenghua Shi, 2010 .

Table 5B, Submission information on Probe#2: CID1542103 and analogs

Susanne Heynen-Genel, Michelle Sauer, Shenghua Shi, 2010 .

[Table, A tabular presentation summarizing known probe properties (computed properties, must match from PubChem)].

Susanne Heynen-Genel, Michael Vicchiarelli, Shenghua Shi, 2011 .

[Table, Image Acquisition and Analysis].

Susanne Heynen-Genel, Michelle Sauer, Shenghua Shi, 2011 .

Figure 2, The GPR35 Antagonist Probe Flowchart summarizes the compound triage and decision tree for advancement of the compounds

Susanne Heynen-Genel, Michelle Sauer, Shenghua Shi, 2010 .

Mutation Studies of Ser7.39 and Ser2.60 in the Human CB1 Cannabinoid Receptor: Evidence for a Serine-Induced Bend in CB1 Transmembrane Helix 7

Daniel Fleischer, Mary E Abood, Alexandros Makriyannis, 2007, Molecular Pharmacology.

Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands*

Marc G Caron, Pingwei Zhao, Mary E Abood, 2009, The Journal of Biological Chemistry.

An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region.

Mary E Abood, Sharon Anavi-Goffer, Dow P Hurst, 2003, Journal of medicinal chemistry.